Innovative MicroRNA Conjugation for Targeted Therapeutics

This chapter explores an innovative strategy that employs microRNA-146a for developing targeted treatments for inflammatory and myeloid diseases. It highlights the effective delivery methods and promising results in antitumor effects, particularly for patients receiving CAR T-cell therapy.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app